Michael Hill talks with Diabetes in Control Publisher Steve Freed during a Skype interview.
In part 4 of this Exclusive Interview, Michael Hill explains the safety of the MiniMed 670G System and the results of the clinical trial, which included testing incidences of DKA and severe hypoglycemia requiring assistance.
Michael Hill is the Vice President of Global Marketing at Medtronic for Intensive Insulin Management.
To view other segments in this video series:
Part 1: 670G Intro
Part 2: How It Works
Part 3: System Accuracy